6 DECEMBER 2025Healthcare in 2025 has crossed a significant threshold: the system is finally catching diseases before patients are aware they're sick.The shift is most visible in Alzheimer's research, where blood-based biomarkers and foundation models trained on millions of brain scans are identifying pathology years before cognitive decline appears. Clinics are enrolling patients into precision trials based on genetic risk profiles and amyloid staging--not memory complaints. Families get answers earlier, when interventions actually matter.Orthopedic care is following a similar trajectory. Regenerative medicine, using biologics, exosomes and tissue engineering, has moved from experimental to routine. Patients facing joint replacement are now trialing therapies that regenerate cartilage rather than remove it. Recovery timelines have compressed; surgical thresholds have risen.Fertility care has become genuinely predictive. AI-guided embryo selection, non-invasive chromosomal screening and continuous hormone monitoring are improving IVF success rates while reducing the physical and emotional toll. Time-lapse imaging and metabolic profiling result in fewer failed cycles and increased transparency around what's actually viable.What ties these advances together is a fundamental reorientation toward interception rather than reaction. The global healthcare analytics market, projected to reach $198.79 billion by 2033 at a 14.85 percent CAGR, reflects how data intelligence has become the infrastructure enabling this shift.Predictive care isn't coming. It's already standard practice for those who can access it.The magazine features insights from Laura Silverstein, Administrator/Director of Patient Service at True Care Home Care, who shares how specialized home care supports individuals with Alzheimer's through acceptance, education and Certified Dementia Specialists who help families maintain dignity and safety at home.Further perspective comes from Robert Fink, Vice President, Pharmacy Services - Chief Pharmacy Executive at UofL Health, who explains how a pharmacist-led model, leveraging 340B pricing, Medication Therapy Management clinics and targeted incentives, helps manage rising drug costs while improving access and outcomes.We hope this edition offers guidance that helps individuals, families and caregivers navigate an evolving healthcare landscape with confidence.Let us know your thoughts!Healthcare Stopped Waiting for Symptoms to Show UpEditorialManaging EditorLyra HawthorneEditorial StaffAaron PaulJoe PhillipJames SmithMark RobertVisualizersCopyright © 2025 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER 2025, Volume 03 - Issue 08 (ISSN 3066-6457)Published From ValleyMedia, Inc. 600 S ANDREWS AVE STE 405, FT LAUDERDALE, FL 33301 To subscribe to Medical Care ReviewVisit www.medicalcarereview.com Disclaimer : *Some of the Insights are based on our interviews with CIOs and CXOsEmail:sales@medicalcarereview.comeditor@medicalcarereview.commarketing@medicalcarereview.comSamaelRobert Grey SmithLyra HawthorneManaging Editoreditor@medicalcarereview.com
< Page 5 | Page 7 >